Find uplifting stories about heroes, innovations, and solutions
6533 results for "** depression treatment"
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
Thousands of people told their depression was "treatment-resistant" found relief when doctors treated their cardiovascular system instead of their brain. The discovery could transform care for the 30% of depression patients who don't respond to traditional medications.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
Serenity Mental Health Centers just brought innovative ketamine therapy to Nocatee, Florida, offering new hope for patients struggling with depression and anxiety. The treatment is part of a personalized care approach that's breaking down barriers to mental health support.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
A major clinical trial shows magnetic seizure therapy treats severe depression as effectively as electroconvulsive therapy, but with far fewer memory problems. This breakthrough could help thousands who avoid current treatments due to cognitive side effects.
Scientists discovered a simple blood marker that predicts which depression patients will respond to the most common antidepressants, potentially sparing millions from months of trying different medications. This breakthrough could transform how doctors treat the 330 million people worldwide living with major depression.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
Scientists found that brain cells in young people with depression work overtime when resting but can't keep up under stress. This breakthrough could lead to earlier diagnosis and better treatments for millions struggling with the condition.
A major clinical trial found that caffeine worked better than tiny doses of LSD for treating depression, challenging years of Silicon Valley hype. The research suggests microdosing's benefits may be mostly placebo effect.
For the first time, Americans can treat depression at home using a headset that gently stimulates the brain with electricity. The FDA's approval of this medication-free approach marks a major shift in mental health care.
People with depression who haven't responded to medication found new hope through a strict low-carb diet in a groundbreaking Oxford study. The ketogenic approach delivered measurable improvements after just six weeks.
New research shows one ketamine infusion can reduce severe depression symptoms within hours, not weeks. For people with treatment-resistant depression, this rapid-acting treatment offers hope when traditional antidepressants fail.
A quick, personalized brain stimulation therapy is now available in Arkansas for people whose depression hasn't responded to medication or counseling. The FDA-approved SAINT system at UAMS takes just five days and helps restore normal brain function.
A groundbreaking treatment focuses on rebuilding patients' capacity for happiness rather than just reducing negative feelings, showing better results than standard therapy. Nearly 90% of people with depression struggle to feel joy, a symptom most treatments ignore.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
Showing 20 of 6533